Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

Despite the relevant antitumor efficacy of immunotherapy in advanced non-small cell lung cancer (NSCLC), the results in patients whose cancer harbors activating epidermal growth factor receptor (EGFR) mutations are disappointing. The biological mechanisms underlying immune escape and both unresponsi...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Passarelli, Anna, Aieta, Michele, Sgambato, Alessandro, Gridelli, Cesare
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371983/
https://ncbi.nlm.nih.gov/pubmed/32760402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01479
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items